HNB
REGN icon

Hilltop National Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Hilltop National Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$75.5K Hold
106
– – 0.02% 369
2024
Q3 		$111K Hold
106
– – 0.03% 297
2024
Q2 		$111K Hold
106
– – 0.04% 284
2024
Q1 		$102K Buy
+106
New +$101K 0.03% 300

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hilltop National Bank's REGN Position: Q4 2024 in Review

Hilltop National Bank held its Regeneron Pharmaceuticals (REGN) position steady in Q4 2024 at 106 shares worth $75.5K. The position accounts for 0.02% of the portfolio, ranked #369.

Hilltop National Bank first reported a position in REGN in Q1 2024 and has held it in 4 quarters since. The position peaked at $111K in Q3 2024. 1,317 funds tracked by Wall St. Rank hold REGN as of Q4 2024.

  • Hilltop National Bank held 106 shares of Regeneron Pharmaceuticals worth $75.5K as of Q4 2024.
  • Hilltop National Bank left its Regeneron Pharmaceuticals share count unchanged in Q4 2024.
  • Regeneron Pharmaceuticals made up 0.02% of Hilltop National Bank's portfolio in Q4 2024, its #369 holding.
  • Hilltop National Bank first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • Hilltop National Bank's Regeneron Pharmaceuticals position peaked at $111K in Q3 2024.
  • 1,317 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.

Based on Hilltop National Bank's 13F filing for Q4 2024, filed 10 Jan 2025.